PHENYLEPHRINE BAXTER (Baxter Healthcare Pty Ltd)
Product name
PHENYLEPHRINE BAXTER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
phenylephrine hydrochloride
Registration type
New generic medicine
Indication
Phenylephrine hydrochloride is intended for the maintenance of an adequate level of blood pressure during spinal and inhalation anaesthesia and for the treatment of vascular failure in shock, shock-like states, and drug-induced hypotension, or hypersensitivity. It is also employed to overcome paroxysmal supraventricular tachycardia, to prolong spinal anaesthesia, and as a vasoconstrictor in regional analgesia.